Interestingly, a population-based cohort study revealed that PD incidence in patients with diabetes might vary according to their anti-diabetic treatment and that especially the use of GLP‐1 agonists and/or DPP-4 inhibitors are associated with a lower PD incidence (Brauer et al. 2020). The gene discussed is GCG; the disease is Parkinson disease.